MLC901 (NeuroAiD II™) for cognition after traumatic brain injury: a pilot randomized clinical trial

Background and purpose Treatments to facilitate recovery after traumatic brain injury (TBI) are urgently needed. We conducted a 9‐month pilot, randomized placebo‐controlled clinical trial to examine the safety and potential effects of the herbal supplement MLC901 (NeuroAiD II™) on cognitive function...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of neurology Jg. 25; H. 8; S. 1055 - e82
Hauptverfasser:	Theadom, A., Barker‐Collo, S., Jones, K. M., Parmar, P., Bhattacharjee, R., Feigin, V. L.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England John Wiley & Sons, Inc 01.08.2018 John Wiley and Sons Inc
Schlagworte:	Adults Anxiety Brain Central nervous system Clinical trials Cognition Cognitive ability cognitive deficits Complications Concussion Executive function Fatigue Fatigue failure Head injuries Herbal medicine Mental depression MLC901 Mood NeuroAiD II Original Quality of life Traumatic brain injury traumatic brain injury cognitive deficits concussion quality of life MLC901 NeuroAiD II
ISSN:	1351-5101, 1468-1331, 1468-1331
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!